A common lab stain can help doctors tell some brain tumors apart
Original title: Tumor-type-specific expression of TTF-1 in primary central nervous system tumors classified by the 2021 WHO criteria.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This looked back at tumor samples from people, and it is a lab clue for doctors, not a treatment.
The short version
A stain called TTF-1 may help doctors name a brain tumor correctly under the microscope.
What was studied. Doctors at one hospital in China looked at tumor tissue from 214 primary brain and spinal cord tumors, diagnosed between 2021 and 2024. They stained each sample for TTF-1 and compared the results with the tumor type and grade.
What they found. TTF-1 showed up in 89.47% of central neurocytomas. Among one group of more contained tumors, it showed up only in a type called SEGA. It also showed up now and then in fast growing gliomas, and in some tumors of the covering tissue inside the skull that carry a change called FET-CREB. It was absent in many rare tumor types.
What this means, and what it doesn't
What it could mean: If you have a brain tumor that is hard to name, this stain may give the pathologist one more clue. The authors warn that a positive result does not always mean the tumor spread from the lung or thyroid. Read carefully, the stain may help avoid a wrong diagnosis.
What it doesn't mean: This is not a treatment, and it is not a cure. It is a lab test done on tumor tissue after surgery or biopsy. It does not slow or stop a tumor. The work was done at one hospital and looked back at past cases, so other hospitals may see different results. Nothing here changes what care you can get today.
Source: PubMed, July 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.